• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NOVA BIOMEDICAL CORP NOVAMAX LINK GLUCOSE MONITOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NOVA BIOMEDICAL CORP NOVAMAX LINK GLUCOSE MONITOR Back to Search Results
Catalog Number 44585
Device Problems Incorrect, Inadequate or Imprecise Result or Readings (1535); Improper or Incorrect Procedure or Method (2017); Component Missing (2306)
Patient Problems Hyperglycemia (1905); Hypoglycemia (1912)
Event Date 09/10/2014
Event Type  malfunction  
Event Description
It was reported to nova biomedical that a consumer received a result to 209 mg/dl on their blood glucose meter.The consumer immediately performed another test using the same meter and strips from the same vital getting the following result of 37 mg/dl.Subsequently, the consumer experienced a hypoglycemic event requiring emergent flood intervention to help raise his blood glucose level.During the call to customer support, it was revealed that the consumer did not control solution test for integrity before use their initial test strips as instructed in our directions for use.While on the phone, a control solution could not be performed because the consumer did not have any control solution.Control solution was shipped the next day to consumer and a follow up call was made to customer support, and it was during this call to customer support, a control solution test was performed while troubleshooting with customer support showing the test strips to fall in range.The difference in the consumer's readings was determined to be clinically significant.The meter and test strips will be returned for evaluation.
 
Manufacturer Narrative
Nova max test strip insert - qual control checking the sys control solution test: the nova max control solution is used as a qual control check to make sure that your blood glucose monitor and the nova max glucose test strips are working correctly.Do a control solution test: each time you open a new vial of test strips.Nova biomedical awaits the return of the device for evaluation.Should any significant findings be a result of that investigation, a follow-up report will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NOVAMAX LINK GLUCOSE MONITOR
Type of Device
GLUCOSE MONITOR
Manufacturer (Section D)
NOVA BIOMEDICAL CORP
200 prospect st
waltham MA 02454
Manufacturer Contact
kathleen duke, rn, compliance mgr
200 prospect st
waltham, MA 02454-1406
7818940800
MDR Report Key4125808
MDR Text Key4918737
Report Number3004193489-2014-00088
Device Sequence Number1
Product Code CGA
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K040603
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Unknown
Type of Report Initial
Report Date 09/10/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/23/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Catalogue Number44585
Device Lot Number1020814091
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received09/10/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/04/2013
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
EXPIRATION DATE:; CONTROL SOLUTION LOT # 1030214093 RANGE: 82-127 MG; TEST STRIPS LOT # 1020814091
Patient Outcome(s) Required Intervention;
-
-